Page last updated: 2024-12-05

succinic anhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Succinic anhydride is a cyclic anhydride derived from succinic acid. It is a white, crystalline solid with a melting point of 119-120 °C. Succinic anhydride is commonly used as a reagent in organic synthesis. For example, it is used in the synthesis of various pharmaceuticals, agrochemicals, and polymers. Succinic anhydride is also a key component in the production of succinic acid. Succinic acid is a valuable commodity chemical that has applications in the food, pharmaceutical, and chemical industries. Succinic anhydride is an important building block for various polymers, including polyesters and polyamides. It is also used in the synthesis of resins and adhesives. Furthermore, succinic anhydride is a potential platform chemical for the production of bio-based products. Succinic anhydride is also being studied for its potential applications in various fields, such as pharmaceuticals, cosmetics, and food additives. This is due to its unique properties, such as its biocompatibility, low toxicity, and ability to form various derivatives.'

Cross-References

ID SourceID
PubMed CID7922
CHEMBL ID1370164
CHEBI ID36595
SCHEMBL ID16123
MeSH IDM0099681

Synonyms (93)

Synonym
CHEBI:36595 ,
oxolane-2,5-dione
tetrahydro-2,5-furandione
bernsteinsaeureanhydrid
2,5-dioxotetrahydrofuran
tetrahydro-furan-2,5-dione
succinyl anhydride
bernsteinsaure-anhydrid
succinyl oxide
butanedioic anhydride
108-30-5
wln: t5vovtj
2,5-diketotetrahydrofuran
succinic anhydride
2, dihydro-
succinic acid anhydride
nci-c55696
nsc8518
dihydro-2,5-furandione
nsc-8518
tetrahydro-2,5-dioxofuran
succinic anhydride treated bsa
dihydro-furan-2,5-dione
2,5-furandione, dihydro-
butanedioic acid,anhydride succinic anhydride
inchi=1/c4h4o3/c5-3-1-2-4(6)7-3/h1-2h
dihydrofuran-2,5-dione
NCGC00091291-01
ccris 2386
bernsteinsaure-anhydrid [german]
hsdb 792
nsc 8518
brn 0108441
dihydro-2,5-diketotetrahydrofuran
rikacid sa
succinyloxide
einecs 203-570-0
ai3-52664
succinic anhydride, 97%
succinic anhydride, >=99% (gc)
smr001372026
MLS002454448
FT-0652573
S0107
AKOS000121191
A801840
NCGC00091291-02
6rf4o17z8j ,
ec 203-570-0
unii-6rf4o17z8j
5-17-11-00006 (beilstein handbook reference)
C19524
HMS3039B10
dtxcid701287
cas-108-30-5
tox21_201179
dtxsid7021287 ,
NCGC00258731-01
68412-02-2
einecs 270-161-1
BP-13070
FT-0637061
succinic anhydride [inci]
succinic anhydride [hsdb]
succinic anhydride [mi]
succinic anhydride [iarc]
SCHEMBL16123
butanedioic acid anhydride
tetrahydrofuran-2,5-dione
2,5(3h,4h)-furandione
STR01303
CHEMBL1370164
CS-0011581
mfcd00005525
J-002088
F1908-0090
succinic anhydride, saj first grade, >=99.0%
succinic anhydride, puriss., >=99.0% (nt)
succinic anhydride, >=97.0% (nt)
D78120
tetrahydro-2, 5-dioxofuran
butanedioic acid,anhydride succinic anhydride
dihydro-2, 5-furandione
Z57127506
HY-79369
Q417847
STL194303
oxolan-2,5-dione
EN300-18021
succinicanhydride-13c4
bernsteinsaureanhydrid
succinic anhydride (iarc)
tetrahydro-2,5-furandione(national library of medicine, sis; chemidplus record for succinic anhydride (108-30-5) available from, as of july 21, 2005: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp)

Research Excerpts

Effects

ExcerptReferenceRelevance
"Succinic anhydride has been frequently used in adhesives and sealant chemicals for a long time, and here, it is evaluated for dye removal performance."( Synthesis, characterization and adsorption behavior of modified cellulose nanocrystals towards different cationic dyes.
Akhtar, MS; Aljuwayid, AM; Alothman, ZA; Aziz, T; Chinnam, S; Farid, A; Habila, MA; Haq, F; Kiran, M; Wani, AW, 2023
)
1.63

Bioavailability

ExcerptReferenceRelevance
" The developed drug delivery system possessed the profound significance in improving pharmacodynamics and bioavailability of drugs."( Cellulose-based film modified by succinic anhydride for the controlled release of domperidone.
Cui, Y; Shi, C; Tao, F, 2018
)
0.76
" Future perspectives will concern OSA-polysaccharides-based nano-encapsulation systems with optimized functional properties for providing higher bioavailability and targeted delivery of various hydrophobic bioactive compounds."( Recent advances of octenyl succinic anhydride modified polysaccharides as wall materials for nano-encapsulation of hydrophobic bioactive compounds.
Geng, Z; Liu, Y; Rehman, A; Tong, Q; Xu, W; Yin, L; Zhao, L, 2022
)
1.02
" Our work showed that OSA-pre-treatment ultrasonic rice starch could improve curcumin bioavailability by increasing the encapsulation efficiency with stronger stability to avoid the attack of enzymes and high intensity ion, providing a way to develop new emulsion-based delivery systems for bioactive lipophilic compounds using OSA starch."( Application of Curcumin Emulsion Carrier from Ultrasonic-Assisted Prepared Octenyl Succinic Anhydride Rice Starch.
Fang, H; Tian, J; Wei, X; Zhang, H; Zheng, Y, 2022
)
0.95

Dosage Studied

ExcerptRelevanceReference
" Conjugates, prepared with rARU or succinylated (rARUsucc), were administered to mice by a clinically relevant dosage and immunization scheme."( Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice.
Bryla, DA; Lyerly, DM; Moncrief, JS; Pavliakova, D; Robbins, JB; Schiffman, G; Schneerson, R, 2000
)
0.31
" Brain targeted delivery was achieved and a reduction in dosage might be allowed."( Body distributioin of RGD-mediated liposome in brain-targeting drug delivery.
Chen, B; Chen, D; Hu, H; Qiao, M; Qin, J; Zhao, X, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
cyclic dicarboxylic anhydrideAn acid anhydride derived by loss of water between two carboxylic groups in the same molecule so as to close a ring.
tetrahydrofurandione
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.00690.006038.004119,952.5996AID1159521
thyroid stimulating hormone receptorHomo sapiens (human)Potency1.25890.001318.074339.8107AID926; AID938
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.06310.000214.376460.0339AID588532
gemininHomo sapiens (human)Potency0.74200.004611.374133.4983AID624296; AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (248)

TimeframeStudies, This Drug (%)All Drugs %
pre-199029 (11.69)18.7374
1990's32 (12.90)18.2507
2000's48 (19.35)29.6817
2010's88 (35.48)24.3611
2020's51 (20.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 89.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index89.03 (24.57)
Research Supply Index5.56 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index158.19 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (89.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.39%)5.53%
Reviews3 (1.16%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other254 (98.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]